Exact Sciences Corporation

This study follows 150,000 adults in the U.S. who were prescribed the Cologuard stool test for colorectal cancer screening. Researchers want to see how many people get a follow-up colonoscopy after a positive result, how often cancer is found, and whether the test helps lower dea…

This study is testing a new blood test called Oncoguard™ Liver to see how well it finds liver cancer early in people who are at high risk, such as those with cirrhosis or hepatitis B. About 3,000 adults will take part, and the test's accuracy will be compared to standard ultrasou…

This study is testing a blood test that looks for tiny bits of tumor DNA (ctDNA) to see if it can predict when colorectal cancer might return after surgery. About 1,000 people with stage II or III colorectal cancer who had their tumor completely removed will be followed for up to…